Literature DB >> 12149044

Management strategies for male factor infertility.

Gerhard Haidl1.   

Abstract

Although modern assisted reproduction techniques contribute a lot to overcoming severe male factor infertility, application of these methods in every infertile couple would represent an over-treatment. Therefore, conventional treatment modalities are still the first approach to male fertility disorders. Apart from assisted reproduction techniques, these include surgical procedures and the administration of drugs. Causal treatment regimens of proven effectiveness are only available for patients with infertility resulting from hypogonadotrophic hypogonadism. Drug treatment of retrograde ejaculation is also effective. Inconsistent results have been obtained with empirical treatment including antiestrogens, androgens, aromatase-inhibitors, mast cell blockers, zinc and pentoxifylline. Anti-inflammatory and immunosuppressive therapy as well as treatment with antioxidants in the presence of reactive oxygen species has not yet been demonstrated to be effective by controlled studies but represent at least a rational approach which should be investigated more thoroughly. High dosage administration of follicle stimulating hormone aimed particularly at improving disturbed sperm structures, and the combination of tamoxifen with androgens, may be promising developments. A careful diagnostic work-up is necessary before any andrological treatment is commenced so that adequate treatment options can be selected for individual patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149044     DOI: 10.2165/00003495-200262120-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  57 in total

1.  Which efforts towards conservative treatment of male infertility will be successful? Antibiotic therapy.

Authors:  W Weidner
Journal:  Andrologia       Date:  1999-09       Impact factor: 2.775

2.  Changes in seminal quality following oral zinc therapy.

Authors:  H G Kynaston; D I Lewis-Jones; R V Lynch; A D Desmond
Journal:  Andrologia       Date:  1988 Jan-Feb       Impact factor: 2.775

3.  The use of ebastine, a mast cell blocker, for treatment of oligozoospermia.

Authors:  S Matsuki; I Sasagawa; Y Suzuki; H Yazawa; T Tateno; T Hashimoto; T Nakada; H Saito; M Hiroi
Journal:  Arch Androl       Date:  2000 Mar-Apr

4.  Effect of corticosteroids on sperm antibody concentration in different biological fluids and on pregnancy outcome in immunologic infertility.

Authors:  Z Ulcova-Gallová; V Bouse; Z Rokyta; K Krizanovská
Journal:  Zentralbl Gynakol       Date:  2000

5.  The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia.

Authors:  D A Adamopoulos; S Nicopoulou; N Kapolla; M Karamertzanis; E Andreou
Journal:  Fertil Steril       Date:  1997-04       Impact factor: 7.329

6.  The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection.

Authors:  J Ashkenazi; I Bar-Hava; J Farhi; T Levy; D Feldberg; R Orvieto; Z Ben-Rafael
Journal:  Fertil Steril       Date:  1999-10       Impact factor: 7.329

7.  Lipid peroxidation and human sperm motility: protective role of vitamin E.

Authors:  S A Suleiman; M E Ali; Z M Zaki; E M el-Malik; M A Nasr
Journal:  J Androl       Date:  1996 Sep-Oct

Review 8.  Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administration.

Authors:  H Tournaye; A C Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  1994-06       Impact factor: 6.918

9.  Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility.

Authors:  A Lenzi; F Culasso; L Gandini; F Lombardo; F Dondero
Journal:  Hum Reprod       Date:  1993-10       Impact factor: 6.918

10.  Placebo-controlled trial of high-dose Mesterolone treatment of idiopathic male infertility.

Authors:  J Gerris; F Comhaire; P Hellemans; K Peeters; F Schoonjans
Journal:  Fertil Steril       Date:  1991-03       Impact factor: 7.329

View more
  8 in total

Review 1.  [Orchitis and male infertility].

Authors:  H-C Schuppe; A Pilatz; H Hossain; A Meinhardt; M Bergmann; G Haidl; W Weidner
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

Review 2.  Cutting-edge issues in autoimmune orchitis.

Authors:  Clovis A Silva; Marcello Cocuzza; Eduardo F Borba; Eloísa Bonfá
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 3.  Contemporary concepts in the evaluation and management of male infertility.

Authors:  Kathleen Hwang; R Chanc Walters; Larry I Lipshultz
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

Review 4.  Major regulatory mechanisms involved in sperm motility.

Authors:  Rute Pereira; Rosália Sá; Alberto Barros; Mário Sousa
Journal:  Asian J Androl       Date:  2017 Jan-Feb       Impact factor: 3.285

5.  Nonsurgical treatment of male infertility: specific and empiric therapy.

Authors:  Marcello Cocuzza; Ashok Agarwal
Journal:  Biologics       Date:  2007-09

6.  Resveratrol reverses cadmium chloride-induced testicular damage and subfertility by downregulating p53 and Bax and upregulating gonadotropins and Bcl-2 gene expression.

Authors:  Samy M Eleawa; Mahmoud A Alkhateeb; Fahaid H Alhashem; Ismaeel Bin-Jaliah; Hussein F Sakr; Hesham M Elrefaey; Abbas O Elkarib; Riyad M Alessa; Mohammad A Haidara; Abdullah S Shatoor; Mohammad A Khalil
Journal:  J Reprod Dev       Date:  2014-02-01       Impact factor: 2.214

7.  Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism.

Authors:  J Rajkanna; S Tariq; S O Oyibo
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-01-07

Review 8.  Systematic review of hormone replacement therapy in the infertile man.

Authors:  Amr El Meliegy; Ahmad Motawi; Mohamed Ahmed Abd El Salam
Journal:  Arab J Urol       Date:  2017-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.